Overview
- Highlights the crucial role of novel PET radiopharmaceuticals in the clinical usefulness of PET
- Features approx. 20 radiopharmaceuticals and their role in clinics
- PET/CT acquisition protocols, specific to each tracer, are presented in each chapter
- Provides over 50 multi-imaging figures (contrast enhanced CT and/or PET/CT and/or SPECT and/or PET/MRI and/or MRI)
- Presents numerous clinical cases, with multi-tracer evaluation in a single patient, revealing mismatches or diagnostic overlap
Access this book
Tax calculation will be finalised at checkout
Other ways to access
Table of contents (13 chapters)
-
Front Matter
Keywords
About this book
The book reflects the rapid development of several PET tracers over the last decade, as a result of which the “traditional” PET/CT with 18F-FDG, the “cornerstone” of PET imaging, is now only one of several available options, which use different tracers for different diseases. For the same reason, PET imaging is no longer limited to the field of oncology.
In the editors’ experience, students in medicine and residents in nuclear medicine and radiology have limited access to scientific papers concerning novel PET tracers. Moreover, these papers generally focus on a single PET radiopharmaceutical. With approx. 20 radiopharmaceuticals explained in detail and a wealth of images and clinical cases, the book represents a versatile, comprehensive and practice-oriented guide to PET imaging, pursuing a unique andnovel approach to the clinical role of PET tracers.
The book’s didactic nature also makes it an invaluable tool for residents in nuclear medicine and radiology, as well as for radiographers and clinicians in radiotherapy, oncology, hematology, cardiology and neurology.
Editors and Affiliations
About the editors
Prof. Orazio Schillaci graduated with a degree in Medicine in 1990 and specialized in Nuclear Medicine in 19942 at the University of Rome “La Sapienza.” He began his scientific work at the University of L’Aquila: during this important period, Schillaci started exploring molecular imaging, with an emphasis on SPECT for neuroendocrine tumors. After a research stay in California, USA, he became a Professor of Nuclear Medicine at the University of Rome “Tor Vergata” in 2001. Since 2008 he has led the School of Specialization in Nuclear Medicine and, since 2013, has been Director of the School Of Medicine at the “Tor Vergata” University Hospital in Rome. The author of more than 220 scientific articles listed in PubMed, his current research interest is in the development of novel PET radiopharmaceuticals and their potential clinical applications in oncology, neurology, cardiology and infectious disease, within a network involving several Italian and European institutions. Most recently, he became President of the Italian Association of Nuclear Medicine (AIMN).
Bibliographic Information
Book Title: Radiopharmaceuticals
Book Subtitle: A Guide to PET/CT and PET/MRI
Editors: Ferdinando Calabria, Orazio Schillaci
DOI: https://doi.org/10.1007/978-3-030-27779-6
Publisher: Springer Cham
eBook Packages: Medicine, Medicine (R0)
Copyright Information: The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG 2020
Hardcover ISBN: 978-3-030-27778-9Published: 25 October 2019
Softcover ISBN: 978-3-030-27781-9Published: 25 October 2020
eBook ISBN: 978-3-030-27779-6Published: 12 October 2019
Edition Number: 2
Number of Pages: XII, 234
Number of Illustrations: 9 b/w illustrations, 184 illustrations in colour
Topics: Nuclear Medicine, Oncology, Radiotherapy, Hematology, Neurology